Scientists have uncovered the hidden danger of how high iron levels from red meat may increase the risk of colorectal cancer, a leading cause of cancer-related deaths worldwide. The findings could pave the way for new treatments that target a key cancer-promoting enzyme.
Researchers from the Agency for Science, Technology and Research (A*STAR) and the National Cancer Centre Singapore (NCCS) identified how iron contributes to cancer growth by reactivating telomerase. This enzyme allows cancer cells to multiply uncontrollably.
Their study, published in Cancer Discovery, sheds light on the long-debated link between diet and colorectal cancer development.
Iron interacts with a protein to fuel tumor growth
Colorectal cancer, which affects the colon or rectum, is the second leading cause of cancer-related deaths in Singapore. While genetics and lifestyle factors play a role, the precise mechanism connecting red meat consumption to cancer risk remained unclear—until now.
The research team analyzed colorectal cancer samples and used advanced lab models to study how iron influences cancer progression. They found that iron interacts with a protein called Pirin, which activates telomerase. This process fuels tumor growth, making cancer more aggressive.
Navigating Diet, Genetics, and Colorectal Cancer Risk
A recent epidemiological study published in Cancer Epidemiology, Biomarkers & Prevention delves into how genetic variations might influence the impact of red and processed meat consumption on colorectal cancer risk.… pic.twitter.com/yDzayzLk6e
— Rupa Health (@Rupa_Health) June 25, 2024
“Understanding the role of iron in telomerase activation opens up new avenues for addressing colorectal cancer,” said Professor Vinay Tergaonkar, Distinguished Principal Investigator at A*STAR IMCB.
“Our future research will focus on refining therapeutic strategies that target this mechanism, with the hope of developing more effective treatments for patients, particularly those with high iron levels. We are excited about the potential of small molecules like SP2509 to revolutionize cancer care and improve outcomes for patients globally.”
Potential treatment for red meat-related cancer
The study also revealed a promising treatment strategy while explaining iron’s cancer-promoting effects. Researchers identified SP2509, a small molecule that prevents iron from interacting with Pirin, effectively stopping telomerase reactivation.
Lab tests on colorectal cancer cell lines showed that SP2509 blocked telomerase activation and slowed tumor growth. The discovery offers a new therapeutic option that could benefit patients with high iron levels, who may be at greater risk.
The findings will contribute to Colo-SCRIPT, Singapore’s national research program to reduce colorectal cancer incidence and improve patient outcomes. The program focuses on how environmental, metabolic, and microbial factors influence cancer progression.
“Through Colo-SCRIPT, we will continue to investigate the role of iron and other risk factors and their influence on how colorectal cancer develops. Findings provide valuable insights into how they drive different subtypes of colorectal cancer and can allow us to identify novel methods to prevent and treat the disease,” said Associate Professor Iain Tan, Senior Consultant in the Division of Medical Oncology, NCCS.
See all the latest news from Greece and the world at Greekreporter.com. Contact our newsroom to report an update or send your story, photos and videos. Follow GR on Google News and subscribe here to our daily email!

